The University of Manchester team has discovered a protein potentially involved in the spread or ‘metastatic progression’ of tumours.
The researchers believe their findings could lead to new approaches to treating breast cancer as blocking the protein’s actions has the potential to stop cancerous cells migrating.
“What we have identified is a new role for a protein called LPP,” explained Professor Andrew Sharrocks, who headed the research team.
“Until now, this protein was only thought to function at the cell periphery but we have shown that it works in conjunction with another protein – PEA3 – in the cell nucleus.
“PEA3 has already been implicated in the spread of breast cancer but we have found that the LPP molecule is essential for the correct function of PEA3.”
“If we can target the LPP protein and stop it from working in cancerous cells, we have a possible new route to therapy.”
The research, published in the scientific journal Molecular and Cellular Biology, may have implications for other cancer systems.
“Benign tumours remain in one part of the body and are relatively easy to treat through surgery,” said Professor Sharrocks, who is based in the University’s Faculty of Life Sciences.
“But metastases – malignant cancers that spread to other parts of the body – can be much more problematic.
“Our research is potentially fundamental to all types of cancers and has the potential to offer alternative therapies to stop cancers spreading to other organs in the body.”
News of the scientific breakthrough comes as the University announced Breast Cancer Campaign funding for two other research projects worth nearly £300,000.
Dr Andrew Gilmore, also in the Faculty of Life Sciences, has been awarded a grant of £146,000 to examine in more detail a process called ‘anoikis’.
Anoikis is the process whereby the body ambushes and kills roving cells that have gone ‘AWOL’ and are moving around the body without permission – like breast-cancer cells that spread from the breast to form tumours in other parts of the body.
Current breast-cancer treatments have been designed to kick start the anoikis process and kill these rogue cells. But the cancer cells are clever and learn how to avoid being destroyed, which means these treatments no longer work and patients often see their breast cancer return.
Dr Gilmore said: “Understanding more about how the body’s natural defences work and why breast-cancer cells can avoid them will help develop new drugs that can kill invasive cells that have become resistant to standard treatment.”
A further £143,000 has been awarded by the charity to Dr Keith Brennan, again in Life Sciences, to uncover how a group of proteins called Notch are able to protect breast-cancer cells from dying.
“Notch proteins appear to shield breast-cancer cells from the body’s natural defences and also from being destroyed by chemotherapy,” said Dr Brennan.
“This research will help to uncover exactly how Notch proteins have this effect and whether inhibiting their action may be one way of making chemotherapy treatments more effective.”
Pamela Goldberg, Chief Executive of Breast Cancer Campaign, added: “The spread of breast-cancer cells to other areas of the body is the single most important factor in breast-cancer mortality.
“When breast-cancer cells become invasive they become less responsive to treatment and the disease becomes more difficult for a clinician to manage.
“Both these studies could help to develop new drugs which kill breast-cancer cells before they have an opportunity to spread.”
Aeron Haworth | alfa
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences